ARCHIVES

NCI To Offer Expanded Access To Oxaliplatin

This article is from The Cancer Letter archive.

Vol. 28 No. 22 | May 31, 2002

Download PDF Visit The Full Archive

Related Articles

NIH Proposes Stricter Rules On Extramural Research Financial Conflicts

May 21, 2010

MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer.

March 2, 2001

DCE Advisors Approve New Epidemiology RFPs Table Proposed RFA

April 16, 1993

House Committee Approves $1.9 Bil. NCI Budget

July 31, 1992

Conversations With The Cancer Letter: Youle: ACS Stance on Tobacco Sales Is Clear

April 18, 2014

Advocates Ask Genentech To Release FDA Letter On Avastin For Breast Cancer.

September 29, 2006